Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab

Most studies of methotrexate (MTX) in combination with tumor necrosis factor (TNF) inhibitors have focused on treatment-naive patients with early disease. The goal of this study was to evaluate whether previous biologic therapy influenced the impact of concomitant MTX in patients initiating treatmen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Schmalzing, Marc, Behrens, Frank, Schwaneck, Eva C., Koehm, Michaela, Greger, Gerd, Gnann, Holger, Burkhardt, Harald, Tony, Hans-Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2020
Soggetti:
6900
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220320/
https://ncbi.nlm.nih.gov/pubmed/32384515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020201
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi